Response to checkpoint inhibition in lung cancer with molecular driver alterations.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2018.36.15_suppl.e21071
Abstract: e21071Background: Checkpoint inhibitors are widely used in NSCLC. While there is evidence that EGFR mutation driven tumours respond poorly to checkpoint inhibition, little is known about the sensit... read more here.
Keywords: response checkpoint; inhibition lung; checkpoint inhibition; lung cancer ... See more keywords
Response to checkpoint inhibitors (CPI) in sarcomatoid renal cell carcinoma (sRCC).
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2020.38.15_suppl.e17095
Abstract: e17095Background: sRCC have a generally poor prognosis though recent clinical trial data suggest improved outcomes with CPI. We present a real-world experience of metastatic sRCC patients (pts) tre... read more here.
Keywords: srcc; checkpoint inhibitors; response checkpoint; cpi sarcomatoid ... See more keywords
Comment on: Jilkova, Z.M.; et al. “Predictive Factors for Response to PD-1/PD-L1 Checkpoint Inhibition in the Field of Hepatocellular Carcinoma: Current Status and Challenges” Cancers 2019, 11, 1554
Sign Up to like & getrecommendations! Published in 2020 at "Cancers"
DOI: 10.3390/cancers12092670
Abstract: I read with interest the article 'Predictive Factors for Response to PD-1/PD-L1 Checkpoint Inhibition in the Field of Hepatocellular Carcinoma: Current Status and Challenges' [...]. read more here.
Keywords: predictive factors; response checkpoint; factors response; field hepatocellular ... See more keywords